The American BioDefense Institute is a Washington, D.C. based Think Tank, dedicated to nonpartisan analysis of U.S. and international biodefense capabilities and strategies, created in response to the COVID 19 pandemic. ABI challenges the conventional boundaries of scientific disciplines by combining expertise in medicine, biology, chemistry, communication, and public policy to provide multidirectional strategies to meet future biosecurity challenges.
ABI Fellows represent some of the most accomplished academic and private sector pandemic and biodefense experts in the world. This highly specialized Institute advises the United States Congressional and Federal Agency community on next-generation tools, tactics, and procedures for effective biodefense and pandemic relief, as well as briefing federal stakeholders on the next generation of biological warfare threats.
About Ravi Starzl
Our Executive Director
Dr. Starzl is a Systems Scientist in the Language Technologies Institute at Carnegie Mellon University. He received his doctoral degree in Language and Information Technologies from the School of Computer Science at Carnegie Mellon University in 2012. In addition to his research at CMU, Dr. Starzl develops and teaches classes on the topics of Big Data, biotechnology, and advanced software development. Prior to his academic work, Dr. Starzl held several senior positions in private concerns such as the University of Pittsburgh Medical Center and United Therapeutics Corporation. He has also participated in the founding, growth, and sale of several biotechnologies and high-tech startups.